LB Pharmaceuticals Inc
Fundamentals
Oldest to newest| Line | Dec 2024 | Dec 2025 |
|---|---|---|
| Net income | −$63.1M | −$25.2M |
| Operating cash flow | −$53.1M | −$35.2M |
| Free cash flow | −$53.8M | −$35.3M |
| Cash | $23.0M | $250.2M |
| Shares outstanding | 251.7K | 25.3M |
| Line | Dec 2024 | Dec 2025 |
|---|---|---|
| Net income | −$63.1M | −$25.2M |
| Operating cash flow | −$53.1M | −$35.2M |
| Free cash flow | −$53.8M | −$35.3M |
| Cash | $23.0M | $250.2M |
| Shares outstanding | 251.7K | 25.3M |